S
S

Swisscom

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Brooks MacDonald Group, Genmab, Swisscom

EUROPE RESEARCH ROUNDUP- Brooks MacDonald Group, Genmab, Swisscom Sept 6 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Brooks MacDonald Group, Genmab and Swisscom, on Wednesday. HIGHLIGHTS * Brooks MacDonald Group Plc BRK.L : RBC cuts target price to 2,100p from 2,150p * Genmab A/S GMAB.CO : RBC cuts to sector perform from outperform * H&M HMb.ST : Bernstein raises target price to SEK 130 from SEK 125 * Swisscom AG SCMN.S : Beren
A
H
H
H
I
I
S
S
U
H
A
N

Swisscom's quarterly operating profit jumps 20%

UPDATE 1-Swisscom's quarterly operating profit jumps 20% Adds details, CEO quote Aug 3 (Reuters) - Swisscom SCMN.S on Thursday reported a 20% rise in second-quarter operating profit, boosted by growth in its Italian Fastweb division. The group's earnings before interest and taxes (EBIT) rose to 542 million Swiss francs ($616.6 million) in the quarter, a touch below analysts' forecast of 546 million francs in a company-compiled consensus.
S

Swisscom reports 20% rise in Q2 operating profit

Swisscom reports 20% rise in Q2 operating profit Aug 3 (Reuters) - Swisscom SCMN.S on Thursday reported a 20% rise in second-quarter operating profit, boosted by growth in its Italian unit Fastweb. Earnings before interest and taxes (EBIT) rose to 542 million Swiss francs ($616.6 million) in the quarter, a touch below analysts' forecast of 546 million francs in a company-compiled consensus.
S

Swiss stocks - Factors to watch on August 3

Swiss stocks - Factors to watch on August 3 ZURICH/BERLIN, Aug 3 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: UBS UBSG.S UBS Group is laying off employees from Credit Suisse's investment bank this week in New York, a source familiar with the situation said. OERLIKON OERL.S Reported Q2 adjusted EBITDA of 111 million Swiss francs.
A
C
O
S
U

Abrdn, Hargreaves Lansdown, J D Wetherspoon

EUROPE RESEARCH ROUNDUP-Abrdn, Hargreaves Lansdown, J D Wetherspoon July 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Abrdn, Hargreaves Lansdown and J D Wetherspoon on Thursday. HIGHLIGHTS * Abrdn ABDN.L : HSBC raises target price to 190p from 185p * Hargreaves Lansdown HRGV.L : JP Morgan raises target price to 774p from 707p * Hunting Plc HTG.L : Berenberg raises to buy from hold * J D Wetherspoon JDW.L : Stifel raises targe
A
A
B
B
B
B
C
D
D
E
E
E
F
F
G
G
H
H
H
L
N
P
P
S
S
T
T
A
A
A
D

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.